Nexus AG (LON:0FGL)
70.80
-0.20 (-0.28%)
At close: May 6, 2025
Nexus AG Revenue
In the year 2024, Nexus AG had annual revenue of 265.52M EUR with 8.27% growth. Nexus AG had revenue of 71.44M in the quarter ending December 31, 2024, with 0.22% growth.
Revenue
265.52M EUR
Revenue Growth
+8.27%
P/S Ratio
4.64
Revenue / Employee
139.09K EUR
Employees
1,909
Market Cap
1.02B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.52M | 20.28M | 8.27% |
Dec 31, 2023 | 245.24M | 33.73M | 15.95% |
Dec 31, 2022 | 211.51M | 20.80M | 10.91% |
Dec 31, 2021 | 190.71M | 24.75M | 14.91% |
Dec 31, 2020 | 165.96M | 14.46M | 9.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |